Aterian, Inc. (NASDAQ:ATER) Short Interest Up 8.5% in October

Aterian, Inc. (NASDAQ:ATERGet Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totalling 285,500 shares, an increase of 8.5% from the September 30th total of 263,200 shares. Approximately 4.3% of the shares of the company are sold short. Based on an average daily trading volume, of 52,500 shares, the short-interest ratio is currently 5.4 days.

Aterian Trading Up 1.8 %

ATER stock opened at $2.79 on Thursday. The firm has a 50 day moving average of $3.00 and a 200-day moving average of $2.76. The company has a market cap of $23.96 million, a price-to-earnings ratio of -0.81 and a beta of 2.04. Aterian has a 12-month low of $1.90 and a 12-month high of $6.54.

Aterian (NASDAQ:ATERGet Free Report) last posted its earnings results on Thursday, August 8th. The company reported ($0.52) EPS for the quarter, topping analysts’ consensus estimates of ($0.64) by $0.12. The company had revenue of $27.98 million for the quarter. Aterian had a negative return on equity of 64.24% and a negative net margin of 18.88%.

Insider Transactions at Aterian

In related news, Director William Kurtz sold 8,547 shares of Aterian stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $3.01, for a total value of $25,726.47. Following the sale, the director now directly owns 47,216 shares in the company, valued at $142,120.16. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Aterian news, Director William Kurtz sold 8,547 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $3.01, for a total value of $25,726.47. Following the completion of the sale, the director now owns 47,216 shares of the company’s stock, valued at approximately $142,120.16. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO Roi Zion Zahut sold 14,050 shares of the company’s stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of $3.06, for a total transaction of $42,993.00. Following the transaction, the chief technology officer now directly owns 201,494 shares in the company, valued at approximately $616,571.64. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 49,015 shares of company stock valued at $150,562. Corporate insiders own 10.70% of the company’s stock.

Institutional Investors Weigh In On Aterian

Large investors have recently added to or reduced their stakes in the business. B. Riley Wealth Advisors Inc. raised its position in Aterian by 39.8% during the first quarter. B. Riley Wealth Advisors Inc. now owns 24,750 shares of the company’s stock worth $68,000 after acquiring an additional 7,050 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Aterian in the second quarter valued at approximately $59,000. Finally, Essex Investment Management Co. LLC purchased a new position in shares of Aterian during the 3rd quarter worth approximately $102,000. 7.02% of the stock is owned by institutional investors and hedge funds.

About Aterian

(Get Free Report)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.

See Also

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.